- Home
- MBI vs IMMP Comparison
MBI vs IMMP Comparison
Compare MBI & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- IMMP
- Stock Information
- Founded
- MBI 1973
- IMMP 1987
- Country
- MBI United States
- IMMP Australia
- Employees
- MBI N/A
- IMMP N/A
- Industry
- MBI Property-Casualty Insurers
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- IMMP Health Care
- Exchange
- MBI Nasdaq
- IMMP Nasdaq
- Market Cap
- MBI 301.1M
- IMMP 304.0M
- IPO Year
- MBI 1987
- IMMP N/A
- Fundamental
- Price
- MBI $6.05
- IMMP $1.93
- Analyst Decision
- MBI Buy
- IMMP Buy
- Analyst Count
- MBI 2
- IMMP 2
- Target Price
- MBI $6.75
- IMMP $8.50
- AVG Volume (30 Days)
- MBI 416.6K
- IMMP 98.7K
- Earning Date
- MBI 02-26-2025
- IMMP 02-27-2025
- Dividend Yield
- MBI N/A
- IMMP N/A
- EPS Growth
- MBI N/A
- IMMP N/A
- EPS
- MBI N/A
- IMMP N/A
- Revenue
- MBI N/A
- IMMP $2,563,302.00
- Revenue This Year
- MBI N/A
- IMMP N/A
- Revenue Next Year
- MBI N/A
- IMMP $47.79
- P/E Ratio
- MBI N/A
- IMMP N/A
- Revenue Growth
- MBI N/A
- IMMP 9.59
- 52 Week Low
- MBI $3.22
- IMMP $1.66
- 52 Week High
- MBI $7.16
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- MBI 46.25
- IMMP 42.28
- Support Level
- MBI $5.75
- IMMP $2.00
- Resistance Level
- MBI $6.47
- IMMP $2.05
- Average True Range (ATR)
- MBI 0.35
- IMMP 0.09
- MACD
- MBI -0.06
- IMMP -0.02
- Stochastic Oscillator
- MBI 22.73
- IMMP 8.33
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.